Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 36 articles:
HTML format
Text format



Single Articles


    May 2018
  1. LAI X, Stiff A, Duggan M, Wesolowski R, et al
    Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1721559115.
    PubMed     Text format     Abstract available


    March 2018
  2. KE H, Zhao L, Zhang H, Feng X, et al
    Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1714573115.
    PubMed     Text format     Abstract available


    January 2018
  3. THU KL, Silvester J, Elliott MJ, Ba-Alawi W, et al
    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1719577115.
    PubMed     Text format     Abstract available


  4. SAMANTA D, Park Y, Ni X, Li H, et al
    Chemotherapy induces enrichment of CD47(+)/CD73(+)/PDL1(+) immune evasive triple-negative breast cancer cells.
    Proc Natl Acad Sci U S A. 2018 Jan 24. pii: 1718197115.
    PubMed     Text format     Abstract available


  5. DEVIGNES CS, Aslan Y, Brenot A, Devillers A, et al
    HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1718009115.
    PubMed     Text format     Abstract available


    December 2017
  6. DOHERTY MR, Cheon H, Junk DJ, Vinayak S, et al
    Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1713728114.
    PubMed     Text format     Abstract available


    November 2017
  7. BEAUSANG JF, Wheeler AJ, Chan NH, Hanft VR, et al
    T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
    Proc Natl Acad Sci U S A. 2017 Nov 14. pii: 201713863.
    PubMed     Text format     Abstract available



  8. Correction for Sansone et al., Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201718630.
    PubMed     Text format    


    October 2017
  9. BASUDHAR D, Glynn SA, Greer M, Somasundaram V, et al
    Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 27. pii: 201709119.
    PubMed     Text format     Abstract available


  10. SANSONE P, Savini C, Kurelac I, Chang Q, et al
    Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017;114:E9066-E9075.
    PubMed     Text format     Abstract available


    September 2017
  11. HE F, Chiou AE, Loh HC, Lynch M, et al
    Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708161.
    PubMed     Text format     Abstract available


    August 2017
  12. CHANG YS, Jalgaonkar SP, Middleton JD, Hai T, et al
    Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Aug 7. pii: 201700455.
    PubMed     Text format     Abstract available


    July 2017
  13. WRIGHT HJ, Hou J, Xu B, Cortez M, et al
    CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201703791.
    PubMed     Text format     Abstract available


  14. LIU T, Zhang H, Sun L, Zhao D, et al
    FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
    Proc Natl Acad Sci U S A. 2017 Jul 3. pii: 201621486.
    PubMed     Text format     Abstract available


    June 2017
  15. CASCIELLO F, Al-Ejeh F, Kelly G, Brennan DJ, et al
    G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
    Proc Natl Acad Sci U S A. 2017 Jun 19. pii: 201618706.
    PubMed     Text format     Abstract available


    May 2017
  16. JESELSOHN R, Cornwell M, Pun M, Buchwalter G, et al
    Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
    Proc Natl Acad Sci U S A. 2017 May 15. pii: 201620993.
    PubMed     Text format     Abstract available


    March 2017
  17. CHEN IH, Xue L, Hsu CC, Paez JS, et al
    Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.
    Proc Natl Acad Sci U S A. 2017 Mar 7. pii: 201618088.
    PubMed     Text format     Abstract available


  18. SHAHI P, Wang CY, Lawson DA, Slorach EM, et al
    ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression.
    Proc Natl Acad Sci U S A. 2017 Mar 3. pii: 201701690.
    PubMed     Text format     Abstract available


  19. CHEN L, Jenjaroenpun P, Pillai AM, Ivshina AV, et al
    Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
    Proc Natl Acad Sci U S A. 2017 Mar 1. pii: 201701512.
    PubMed     Text format     Abstract available


    February 2017
  20. TAVERA-MENDOZA LE, Westerling T, Libby E, Marusyk A, et al
    Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201615015.
    PubMed     Text format     Abstract available



  21. Correction for Tung et al., beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201702117.
    PubMed     Text format    



  22. Correction for Gasparini et al., Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201700727.
    PubMed     Text format    


    January 2017
  23. TUNG B, Schade B, Cardiff RD, Aina OH, et al
    beta-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201610383.
    PubMed     Text format     Abstract available


  24. CHEN P, Zuo H, Xiong H, Kolar MJ, et al
    Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201614035.
    PubMed     Text format     Abstract available


    November 2016
  25. RANGEL R, Lee SC, Hon-Kim Ban K, Guzman-Rojas L, et al
    Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
    Proc Natl Acad Sci U S A. 2016 Nov 14. pii: 201613859.
    PubMed     Text format     Abstract available



  26. Correction for Wang et al., Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Proc Natl Acad Sci U S A. 2016 Nov 14. pii: 201616959.
    PubMed     Text format    


    October 2016
  27. WANG Z, Li B, Zhou L, Yu S, et al
    Prodigiosin inhibits Wnt/beta-catenin signaling and exerts anticancer activity in breast cancer cells.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201616336.
    PubMed     Text format     Abstract available


  28. FU X, Jeselsohn R, Pereira R, Hollingsworth EF, et al
    FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Proc Natl Acad Sci U S A. 2016;113:E6600-E6609.
    PubMed     Text format     Abstract available


  29. DOBROFF AS, D'Angelo S, Eckhardt BL, Ferrara F, et al
    Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615288.
    PubMed     Text format     Abstract available


    September 2016
  30. DARASH-YAHANA M, Pozniak Y, Lu M, Sohn YS, et al
    Breast cancer tumorigenicity is dependent on high expression levels of NAF-1 and the lability of its Fe-S clusters.
    Proc Natl Acad Sci U S A. 2016 Sep 12. pii: 201612736.
    PubMed     Text format     Abstract available


    August 2016
  31. EVANS KK, Haygood TM, Cooper J, Culpan AM, et al
    A half-second glimpse often lets radiologists identify breast cancer cases even when viewing the mammogram of the opposite breast.
    Proc Natl Acad Sci U S A. 2016 Aug 29. pii: 201606187.
    PubMed     Text format     Abstract available


    June 2016
  32. MUNSON DJ, Egelston CA, Chiotti KE, Parra ZE, et al
    Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR.
    Proc Natl Acad Sci U S A. 2016 Jun 15. pii: 201606994.
    PubMed     Text format     Abstract available


  33. MAHARA S, Lee PL, Feng M, Tergaonkar V, et al
    HIFI-alpha activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
    Proc Natl Acad Sci U S A. 2016 Jun 14. pii: 201602079.
    PubMed     Text format     Abstract available


    March 2016
  34. SYKES EA, Dai Q, Sarsons CD, Chen J, et al
    Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.
    Proc Natl Acad Sci U S A. 2016;113:E1142-51.
    PubMed     Text format     Abstract available


    January 2016
  35. MARTINEZ-IGLESIAS OA, Alonso-Merino E, Gomez-Rey S, Velasco-Martin JP, et al
    Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.
    Proc Natl Acad Sci U S A. 2016;113:E328-37.
    PubMed     Text format     Abstract available


  36. BAUM LG
    Sweet beginning for cancer stem cells.
    Proc Natl Acad Sci U S A. 2016 Jan 15. pii: 201524020.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: